• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    $APLS
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate
    Get the next $AEIS alert in real time by email

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600:

    • S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.
    • Dutch Bros Inc. (NYSE:BROS) will replace PotlatchDeltic Corp. (NASD: PCH) in the S&P MidCap 400 effective prior to the opening of trading on Monday, February 2. S&P MidCap 400 constituent Rayonier Inc. (NYSE:RYN) is acquiring PotlatchDeltic in a deal expected to be completed soon, pending final closing conditions. Rayonier will remain in the S&P MidCap 400 post-merger.
    • S&P SmallCap 600 constituent Advanced Energy Industries Inc. (NASD: AEIS) will replace Comerica Inc. (NYSE:CMA) in the S&P MidCap 400, and Apellis Pharmaceuticals Inc. (NASD: APLS) will replace Advanced Energy Industries in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 2. S&P 500 constituent Fifth Third Bancorp (NASD: FITB) is acquiring Comerica in a deal expected to be completed soon, pending final closing conditions.
    • American Healthcare REIT Inc. (NYSE:AHR) will replace Cadence Bank (NYSE:CADE) in the S&P MidCap 400 effective prior to the opening of trading on Monday, February 2. S&P 500 constituent Huntington Bancshares Inc. (NASD: HBAN) is acquiring Cadence Bank in a deal expected to be completed soon, pending final closing conditions.
    • LegalZoom.com Inc. (NASD: LZ) will replace Elme Communities (NYSE:ELME) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 2. Elme Communities has announced ongoing liquidation activities and is no longer appropriate for the S&P SmallCap 600.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    Jan 30, 2026

    S&P MidCap 400

    Addition

    TTM Technologies

    TTMI

    Information Technology

    Jan 30, 2026

    S&P MidCap 400

    Deletion

    Civitas Resources

    CIVI

    Energy

    Jan 30, 2026

    S&P SmallCap 600

    Addition

    Amneal Pharmaceuticals

    AMRX

    Health Care

    Jan 30, 2026

    S&P SmallCap 600

    Deletion

    TTM Technologies

    TTMI

    Information Technology

    Feb 2, 2026

    S&P MidCap 400

    Addition

    Dutch Bros

    BROS

    Consumer Discretionary

    Feb 2, 2026

    S&P MidCap 400

    Addition

    Advanced Energy Industries

    AEIS

    Information Technology

    Feb 2, 2026

    S&P MidCap 400

    Addition

    American Healthcare REIT

    AHR

    Real Estate

    Feb 2, 2026

    S&P MidCap 400

    Deletion

    Comerica

    CMA

    Financials

    Feb 2, 2026

    S&P MidCap 400

    Deletion

    Cadence Bank

    CADE

    Financials

    Feb 2, 2026

    S&P MidCap 400

    Deletion

    PotlatchDeltic

    PCH

    Real Estate

    Feb 2, 2026

    S&P SmallCap 600

    Addition

    Apellis Pharmaceuticals

    APLS

    Health Care

    Feb 2, 2026

    S&P SmallCap 600

    Addition

    LegalZoom.com

    LZ

    Industrials

    Feb 2, 2026

    S&P SmallCap 600

    Deletion

    Advanced Energy Industries

    AEIS

    Information Technology

    Feb 2, 2026

    S&P SmallCap 600

    Deletion

    Elme Communities

    ELME

    Real Estate

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    [email protected] 

    Media Inquiries

    [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/ttm-technologies-dutch-bros-advanced-energy-industries-and-american-healthcare-reit-set-to-join-sp-midcap-400-others-to-join-sp-smallcap-600-302671845.html

    SOURCE S&P Dow Jones Indices

    Get the next $AEIS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEIS
    $AHR
    $AMRX
    $APLS

    CompanyDatePrice TargetRatingAnalyst
    Dutch Bros Inc.
    $BROS
    3/6/2026$67.00Buy
    DA Davidson
    LegalZoom.com Inc.
    $LZ
    3/4/2026$6.00Equal Weight → Underweight
    Barclays
    Dutch Bros Inc.
    $BROS
    3/2/2026$75.00Neutral → Buy
    Goldman
    S&P Global Inc.
    $SPGI
    2/17/2026$575.00Buy
    BofA Securities
    Rayonier Inc. REIT
    $RYN
    2/13/2026$28.00Outperform → Strong Buy
    Raymond James
    Huntington Bancshares Incorporated
    $HBAN
    2/3/2026$21.00Outperform
    Evercore ISI
    American Healthcare REIT Inc.
    $AHR
    1/29/2026$55.00Outperform
    BMO Capital Markets
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    More analyst ratings

    $AEIS
    $AHR
    $AMRX
    $APLS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rollins James D Iii bought $86,750 worth of Dep Shares-int in 4.50% Ser H Non-Cum Perp Pref Stk (4,915 units at $17.65) (SEC Form 4)

    4 - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Issuer)

    3/4/26 4:57:31 PM ET
    $HBAN
    Major Banks
    Finance

    Director Rollins James D Iii bought $97,700 worth of Dep Shares-int in 5.50% Ser L Non-Cum Perp Pref Stk (4,500 units at $21.71) and bought $72,917 worth of Dep Shares-int in 6.875 % Ser J Non-Cum Perp Pref Stk (2,873 units at $25.38) (SEC Form 4)

    4 - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Issuer)

    3/3/26 7:46:56 PM ET
    $HBAN
    Major Banks
    Finance

    Director Torgow Gary bought $252,902 worth of shares (14,200 units at $17.81), increasing direct ownership by 2% to 943,341 units (SEC Form 4)

    4 - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Issuer)

    2/23/26 5:13:56 PM ET
    $HBAN
    Major Banks
    Finance

    $AEIS
    $AHR
    $AMRX
    $APLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Huntington Bancshares Incorporated to Present at the 2026 RBC Capital Markets Global Financial Institutions Conference

    COLUMBUS, Ohio, March 6, 2026 /PRNewswire/ -- Huntington Bancshares Incorporated (NASDAQ:HBAN) will participate in the 2026 RBC Capital Markets Global Financial Institutions Conference on Wednesday, March 11, 2026. Brant Standridge, president of consumer and regional banking, and Zach Wasserman, chief financial officer, are scheduled to present to analysts and investors at 10:00 AM (Eastern Time). They will discuss business trends, financial performance, and strategic initiatives. The presentation will include forward-looking statements. Webcast InformationInterested investors m

    3/6/26 9:05:00 AM ET
    $HBAN
    Major Banks
    Finance

    Amneal to Participate in Upcoming Investor Conference

    BRIDGEWATER, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) today announced that Chirag Patel, Co-Chief Executive and President, will participate in a fireside chat at the following upcoming investor conference: Barclays 28th Annual Global Healthcare ConferenceDate: March 10, 2026Fireside Chat: Tuesday, March 10, 2026, at 11:00AM ESTLocation: Miami, FL A webcast of the presentation will be available on Amneal's Investor Relations website at https://investors.amneal.com. A replay of the webcast will be available following the event. About AmnealAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX), headquartered in Bridgewater, New Jersey, is a diversified, glob

    3/5/26 4:05:00 PM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    US Secretary of the Interior Doug Burgum to Address CERAWeek by S&P Global in Houston, March 23-27

    World's preeminent energy conference to focus on 'Convergence and Competition: Energy, Technology and Geopolitics.' Learn more at www.ceraweek.comHOUSTON, March 5, 2026 /PRNewswire/ -- Chairman of the National Energy Dominance Council and Secretary of the Interior Doug Burgum will deliver a plenary address to delegates at the 44th annual CERAWeek by S&P Global, March 23-27 in Houston. He will join the world's energy industry leaders, experts, government officials and policymakers, as well as leaders from the technology, financial and industrial communities addressing this year's conference.

    3/5/26 2:27:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $AEIS
    $AHR
    $AMRX
    $APLS
    SEC Filings

    View All

    Amendment: Fifth Third Bancorp filed SEC Form 8-K: Financial Statements and Exhibits

    8-K/A - FIFTH THIRD BANCORP (0000035527) (Filer)

    3/4/26 5:11:44 PM ET
    $FITB
    Major Banks
    Finance

    SEC Form CERT filed by Huntington Bancshares Incorporated

    CERT - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Filer)

    3/4/26 4:41:47 PM ET
    $HBAN
    Major Banks
    Finance

    SEC Form 8-A12B filed by Huntington Bancshares Incorporated

    8-A12B - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Filer)

    3/4/26 4:01:12 PM ET
    $HBAN
    Major Banks
    Finance

    $AEIS
    $AHR
    $AMRX
    $APLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-CEO Patel Chintu converted options into 886,468 shares and covered exercise/tax liability with 361,980 shares, increasing direct ownership by 61% to 1,388,521 units (SEC Form 4)

    4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)

    3/5/26 4:52:25 PM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & Co-CEO Patel Chirag K. covered exercise/tax liability with 350,978 shares and converted options into 886,468 shares, increasing direct ownership by 62% to 1,393,470 units (SEC Form 4)

    4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)

    3/5/26 4:51:58 PM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, Chief Legal Officer Daly Jason B. converted options into 426,819 shares and covered exercise/tax liability with 185,641 shares, increasing direct ownership by 2,274% to 251,784 units (SEC Form 4)

    4 - Amneal Pharmaceuticals, Inc. (0001723128) (Issuer)

    3/5/26 4:32:25 PM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEIS
    $AHR
    $AMRX
    $APLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $AEIS
    $AHR
    $AMRX
    $APLS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    DA Davidson initiated coverage on Dutch Bros with a new price target

    DA Davidson initiated coverage of Dutch Bros with a rating of Buy and set a new price target of $67.00

    3/6/26 8:32:59 AM ET
    $BROS
    Restaurants
    Consumer Discretionary

    LegalZoom.com downgraded by Barclays with a new price target

    Barclays downgraded LegalZoom.com from Equal Weight to Underweight and set a new price target of $6.00

    3/4/26 8:35:56 AM ET
    $LZ
    EDP Services
    Technology

    Dutch Bros upgraded by Goldman with a new price target

    Goldman upgraded Dutch Bros from Neutral to Buy and set a new price target of $75.00

    3/2/26 8:27:57 AM ET
    $BROS
    Restaurants
    Consumer Discretionary

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEIS
    $AHR
    $AMRX
    $APLS
    Financials

    Live finance-specific insights

    View All

    Amneal Reports Fourth Quarter and Full Year 2025 Financial Results

    ‒ Full Year 2025 Performance Met or Exceeded All Guidance Metrics and 2026 Reflects Another Year of Growth – ‒ Q4 2025 Net Revenue of $814 million; GAAP Net Income of $35 million; Diluted Income per Share of $0.11 ‒ ‒ Q4 2025 Adjusted Net Income of $68 million, Adjusted EBITDA of $175 million; Adjusted Diluted EPS of $0.21 ‒ ‒ Full Year 2025 Net Revenue of $3.02 billion; GAAP Net Income of $72 million; Diluted Income per Share of $0.22 ‒ ‒ Full Year 2025 Adjusted Net Income of $269 million; Adjusted EBITDA of $688 million; Adjusted Diluted EPS of $0.83 ‒ ‒ Provides 2026 Financial Guidance of $3.05 to $3.15 billion in net revenue, $720 to $760 million in Adjusted EBITDA, and $0.93 to $1.0

    2/27/26 6:00:00 AM ET
    $AMRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    American Healthcare REIT ("AHR") Announces Fourth Quarter 2025 and Full Year 2025 Results; Issues Full Year 2026 Guidance

    IRVINE, Calif., Feb. 26, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE:AHR) (the "Company," "we," "our," "management," "us," or "AHR") is announcing today its fourth quarter and full year 2025 results and issuing full year 2026 guidance. Key Highlights:Reported GAAP net income attributable to controlling interest of $10.8 million, or $0.06 per diluted share, for the three months ended December 31, 2025; and GAAP net income attributable to controlling interest of $69.8 million, or $0.42 per diluted share, for the year ended December 31, 2025.Reported Normalized Funds

    2/26/26 4:15:00 PM ET
    $AHR
    Real Estate Investment Trusts
    Real Estate

    SM ENERGY PROVIDES 2026 OUTLOOK

    Plan maximizes free cash flow and strengthens balance sheetAccelerates return of capital, including a 10% dividend increase, under an enhanced frameworkDENVER, Feb. 25, 2026 /PRNewswire/ -- SM Energy Company (the "Company" or "SM Energy") (NYSE:SM) today issued its 2026 outlook, designed to maximize free cash flow through disciplined investments in its high-return development projects. It also provided a new stockholder return framework, which includes a 10% increase to its quarterly dividend policy. Accompanying slides can be found on the Company's website at sm-energy.com/investors/news-events/presentations. A conference call is scheduled for 8 a.m. MT/10 a.m. ET on February 26, 2026. Part

    2/25/26 4:11:00 PM ET
    $SM
    Oil & Gas Production
    Energy

    $AEIS
    $AHR
    $AMRX
    $APLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Apellis Pharmaceuticals Inc.

    SC 13G - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 8:47:59 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Dutch Bros Inc.

    SC 13G/A - Dutch Bros Inc. (0001866581) (Subject)

    11/14/24 4:21:31 PM ET
    $BROS
    Restaurants
    Consumer Discretionary

    $AEIS
    $AHR
    $AMRX
    $APLS
    Leadership Updates

    Live Leadership Updates

    View All

    Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

    WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced today that Mikael Dolsten, M.D., Ph.D., has joined the company's board of directors as of March 1. Most recently, Dr. Dolsten served for more than 16 years as chief scientific officer and president, worldwide research, development and medical, at Pfizer, during which he presided over the regulatory approval of more than 36 medicines and vaccines.  "We are thrilled to welcome Mikael to the Apellis Board of Directors," said Cedric Francois, M.D., Ph.D., chief executive officer and co-founder, Apellis. "Mikael is a proven industry leader with deep experience developing innovative medicine

    3/2/26 7:00:00 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    S&P Global Appoints Chief Strategy Officer for Mobility Global Completing New Executive Leadership Team

    Martin Metzker to lead Strategy, Communications and Enterprise Marketing for Mobility Global in preparation for its planned separation into a standalone public companyNEW YORK, Feb. 19, 2026 /PRNewswire/ -- S&P Global (NYSE: SPGI) today announced the appointment of Martin Metzker as Chief Strategy Officer of S&P Global Mobility ("Mobility Global"), effective immediately. Mr. Metzker will be responsible for leading Mobility Global's Strategy function and overseeing Communications and Enterprise marketing for the business as it prepares for its planned separation from S&P Global into a standalone public company. Mr. Metzker joins the company from Boston Consulting Group, and will report to Bil

    2/19/26 4:15:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    RingCentral Set to Join S&P SmallCap 600

    NEW YORK, Feb. 9, 2026 /PRNewswire/ -- RingCentral Inc. (NYSE:RNG) will replace Hillenbrand Inc. (NYSE:HI) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 12. Lone Star Funds is acquiring Hillenbrand in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Feb 12, 2026 S&P SmallCap 600 Addition RingCentral RNG Information Technology Feb 12, 2026 S&P SmallCap 600 Deletion Hillenbrand HI Industrials ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices is the large

    2/9/26 6:08:00 PM ET
    $HI
    $RNG
    $SPGI
    Miscellaneous manufacturing industries
    Consumer Discretionary
    EDP Services
    Technology